A carregar...
Beta protein immunoreactivity is found in the majority of neurofibrillary tangles of Alzheimer's disease.
The presence of dystrophic neurites in most extracellular neurofibrillary tangles (E-NFT) suggests a factor promoting neurite growth in E-NFT. Although the beta-protein detected in E-NFT may fill that role, reports that only 2-10% of E-NFT contain beta-protein whereas 80-100% contain dystrophic neur...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | English |
| Publicado em: |
1992
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1886431/ https://ncbi.nlm.nih.gov/pubmed/1739122 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
| id |
pubmed-1886431 |
|---|---|
| record_format |
dspace |
| spelling |
pubmed-18864312007-06-19 Beta protein immunoreactivity is found in the majority of neurofibrillary tangles of Alzheimer's disease. Perry, G. Cras, P. Siedlak, S. L. Tabaton, M. Kawai, M. Am J Pathol Research Article The presence of dystrophic neurites in most extracellular neurofibrillary tangles (E-NFT) suggests a factor promoting neurite growth in E-NFT. Although the beta-protein detected in E-NFT may fill that role, reports that only 2-10% of E-NFT contain beta-protein whereas 80-100% contain dystrophic neurites suggested that beta-protein does not play an important role. In this study, the authors used two antisera and one monoclonal antibody to beta-protein to establish the effects of tissue preparation and formic acid enhancement on the detection of beta-protein in E-NFT. We found that beta-protein epitopes in E-NFT are sensitive to formaldehyde fixation and are best enhanced by 50% formic acid, whereas beta-protein in senile plaques is best enhanced at higher formic acid concentrations. After treatment with 50% formic acid, beta-protein was found in all E-NFT. Interestingly, after treatment with 10% formic acid, half of intraneuronal-NFT (I-NFT) also contained beta-protein immunoreactivity. The finding that beta-protein immunoreactivity in senile plaques, E-NFT and I-NFT is increased at different formic acid concentrations suggests that beta-protein in each location is in a different conformation. In contrast, no beta-protein immunoreactivity could be found in E-NFT of the brain stem, an area in which dystrophic neurites do not infiltrate E-NFT. These findings indicate a correlation between neuritic infiltration and presence of beta-protein in E-NFT and suggests the two are linked in Alzheimer's disease for E-NFT as well as senile plaques. 1992-02 /pmc/articles/PMC1886431/ /pubmed/1739122 Text en |
| institution |
US National Library of Medicine |
| collection |
PubMed Central |
| language |
English |
| format |
Article |
| topic |
Research Article |
| spellingShingle |
Research Article Perry, G. Cras, P. Siedlak, S. L. Tabaton, M. Kawai, M. Beta protein immunoreactivity is found in the majority of neurofibrillary tangles of Alzheimer's disease. |
| description |
The presence of dystrophic neurites in most extracellular neurofibrillary tangles (E-NFT) suggests a factor promoting neurite growth in E-NFT. Although the beta-protein detected in E-NFT may fill that role, reports that only 2-10% of E-NFT contain beta-protein whereas 80-100% contain dystrophic neurites suggested that beta-protein does not play an important role. In this study, the authors used two antisera and one monoclonal antibody to beta-protein to establish the effects of tissue preparation and formic acid enhancement on the detection of beta-protein in E-NFT. We found that beta-protein epitopes in E-NFT are sensitive to formaldehyde fixation and are best enhanced by 50% formic acid, whereas beta-protein in senile plaques is best enhanced at higher formic acid concentrations. After treatment with 50% formic acid, beta-protein was found in all E-NFT. Interestingly, after treatment with 10% formic acid, half of intraneuronal-NFT (I-NFT) also contained beta-protein immunoreactivity. The finding that beta-protein immunoreactivity in senile plaques, E-NFT and I-NFT is increased at different formic acid concentrations suggests that beta-protein in each location is in a different conformation. In contrast, no beta-protein immunoreactivity could be found in E-NFT of the brain stem, an area in which dystrophic neurites do not infiltrate E-NFT. These findings indicate a correlation between neuritic infiltration and presence of beta-protein in E-NFT and suggests the two are linked in Alzheimer's disease for E-NFT as well as senile plaques. |
| author |
Perry, G. Cras, P. Siedlak, S. L. Tabaton, M. Kawai, M. |
| author_facet |
Perry, G. Cras, P. Siedlak, S. L. Tabaton, M. Kawai, M. |
| author_sort |
Perry, G. |
| title |
Beta protein immunoreactivity is found in the majority of neurofibrillary tangles of Alzheimer's disease. |
| title_short |
Beta protein immunoreactivity is found in the majority of neurofibrillary tangles of Alzheimer's disease. |
| title_full |
Beta protein immunoreactivity is found in the majority of neurofibrillary tangles of Alzheimer's disease. |
| title_fullStr |
Beta protein immunoreactivity is found in the majority of neurofibrillary tangles of Alzheimer's disease. |
| title_full_unstemmed |
Beta protein immunoreactivity is found in the majority of neurofibrillary tangles of Alzheimer's disease. |
| title_sort |
beta protein immunoreactivity is found in the majority of neurofibrillary tangles of alzheimer's disease. |
| publishDate |
1992 |
| url |
https://ncbi.nlm.nih.gov/pmc/articles/PMC1886431/ https://ncbi.nlm.nih.gov/pubmed/1739122 |
| _version_ |
1760482044270346240 |